Altru Health System ( Site 3254) — Grand Forks, North Dakota

Public research footprint of Altru Health System ( Site 3254), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Non-small Cell Lung Cancer · Coronary Artery Disease · Longstanding Persistent Atrial Fibrillation · Myocardial Infarction

Recently updated registry entries

NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)
NCT07513376 — A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated… (Recruiting)
NCT06077760 — A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Altru Health System ( Site 3254)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.